ReviewEuropean journal of nuclear medicine and molecular imaging2013
PET/MR in prostate cancer: technical aspects and potential diagnostic value.
Review in European journal of nuclear medicine and molecular imaging, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02855190 (Pilot Comparative Study of PET/MR and PET/CT With Different Tracers), which is not on this map. Cited by 26 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Pilot Comparative Study of PET/MR and PET/CT With Different Tracers (18F-FDG and 68Gallium Citrate) in the Diagnosis of Periprosthetic Joint Infection
Who cites it
26 citing papers in PubMed.
- First imaging results of an intraindividual comparison of (11)C-acetate and (18)F-fluorocholine PET/CT in patients with prostate cancer at early biochemical first or second relapse after prostatectomy or radiotherapy.European journal of nuclear medicine and molecular imaging · 2014Trial
- From prostate specific antigen to genomic signatures: Advances in biomarkers for prostate cancer diagnosis and prognosis.Translational oncology · 2026Review
- Article
- Development and first-in-human study of PSMA-targeted PET tracers with improved pharmacokinetic properties.European journal of nuclear medicine and molecular imaging · 2024Article
- Validation ofJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2022Article
- MRI/PET Imaging in elevated PSA and localized prostate cancer: a narrative review.Translational andrology and urology · 2021Review
- Article
- A Pilot Study ofFrontiers in oncology · 2021Article
- Histologically Confirmed Diagnostic Efficacy ofJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2020Article
- Polyethyleneimine-Coated Manganese Oxide Nanoparticles for Targeted Tumor PET/MR Imaging.ACS applied materials & interfaces · 2018Article
- The use of PET/CT in prostate cancer.Prostate cancer and prostatic diseases · 2018Review
- Impact ofRadiation oncology (London, England) · 2018Article
- Prostate-specific membrane antigen cleavage of vitamin B9 stimulates oncogenic signaling through metabotropic glutamate receptors.The Journal of experimental medicine · 2018Article
- Patterns of failure after radical prostatectomy in prostate cancer - implications for radiation therapy planning afterEuropean journal of nuclear medicine and molecular imaging · 2017Article
- [PET-CT and PET-MRI of the prostate : FromDer Radiologe · 2017Review
- Comparison of bone scintigraphy andEuropean journal of nuclear medicine and molecular imaging · 2016Article
- A novel alternative to classify tissues from T 1 and T 2 relaxation times for prostate MRI.Magma (New York, N.Y.) · 2016Article
- Biodistribution and radiation dosimetry of (68)Ga-PSMA HBED CC-a PSMA specific probe for PET imaging of prostate cancer.European journal of nuclear medicine and molecular imaging · 2016Article
- Update on advances in molecular PET in urological oncology.Japanese journal of radiology · 2016Review
- Current use of PSMA-PET in prostate cancer management.Nature reviews. Urology · 2016Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PET/MR is a new multimodal imaging technique that is expected to improve diagnostic performance of imaging in conditions in which assessment of changes in soft tissue is important such as prostate cancer. Despite substantial changes in PET technology compared to PET/CT, initial studies have demonstrated that integrated PET/MR provides comparable image quality to that of PET/CT, retaining PET quantification efficacy. In this review we briefly describe technological changes compared to PET/CT that made integrated PET/MR possible, propose acquisition protocols for evaluation of prostate cancer with this new multimodal approach, present initial results concerning the application of PET/MR in prostate cancer, and outline the potential for further clinical applications, focusing on potential incremental value compared to present diagnostic performance.
Indexed as
Identifiers
23703457What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.